Adaptive Biotechnologies Corporation
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Adaptive Biotechnologies Corporation now
Current reporting with the operating signal separated from the noise.
Earnings Flash (ADPT) Adaptive Biotechnologies Corporation Reports Q3 Revenue $83.9M, vs. FactSet Est of $71.6M
Investors are testing whether Adaptive Biotechnologies Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Adaptive Biotechnologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
Investors are testing whether Adaptive Biotechnologies Corporation’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Adaptive Biotechnologies Corporation (ADPT) hit a 52-week high, can the run continue?
The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
The story matters when it changes Adaptive Biotechnologies Corporation’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ADPT filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Adaptive Biotechnologies Corporation, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →